Heart Test Laboratories Inc. Warrant
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.045
- Today's High:
- $0.122
- Open Price:
- $0.045
- 52W Low:
- $0.0351
- 52W High:
- $0.817
- Prev. Close:
- $0.1
- Volume:
- 2304
Company Statistics
- Market Cap.:
- $0
- Book Value:
- -1.234
- Revenue TTM:
- $25174
- Operating Margin TTM:
- -13966.13%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Heart Test Laboratories Inc. Warrant had its IPO on 2022-06-15 under the ticker symbol HSCSW.
The company operates in the Healthcare sector and Medical Devices industry. Heart Test Laboratories Inc. Warrant has a staff strength of 0 employees.
Stock update
Shares of Heart Test Laboratories Inc. Warrant opened at $0.05 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.05 - $0.12, and closed at $0.1.
This is a -3% slip from the previous day's closing price.
A total volume of 2,304 shares were traded at the close of the day’s session.
In the last one week, shares of Heart Test Laboratories Inc. Warrant have increased by +27.63%.
Heart Test Laboratories Inc. Warrant's Key Ratios
Heart Test Laboratories Inc. Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Heart Test Laboratories Inc. Warrant’s revenue was $25174 with a gross profit of $0 and an EBITDA of $-3489156. The EBITDA ratio measures Heart Test Laboratories Inc. Warrant's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Heart Test Laboratories Inc. Warrant’s operating margin was -13966.13% while its return on assets stood at 0% with a return of equity of 0%.
In Q1.3333333333333, Heart Test Laboratories Inc. Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Heart Test Laboratories Inc. Warrant’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-1.094 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Heart Test Laboratories Inc. Warrant’s profitability.
Heart Test Laboratories Inc. Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Heart Test Laboratories Inc. Warrant stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $3.29 million
- Total Liabilities
- $1.83 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $7592
- Dividend Payout Ratio
- 0%
Heart Test Laboratories Inc. Warrant ended 2024 with $3.29 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.29 million while shareholder equity stood at $230557.00.
Heart Test Laboratories Inc. Warrant ended 2024 with $0 in deferred long-term liabilities, $1.83 million in other current liabilities, 10118.00 in common stock, $-60757198.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.66 million and cash and short-term investments were $1.66 million. The company’s total short-term debt was $529,535 while long-term debt stood at $500000.00.
Heart Test Laboratories Inc. Warrant’s total current assets stands at $2.70 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $319381.00 compared to accounts payable of $631369.00 and inventory worth $676359.00.
In 2024, Heart Test Laboratories Inc. Warrant's operating cash flow was $0 while its capital expenditure stood at $7592.
Comparatively, Heart Test Laboratories Inc. Warrant paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.1
- 52-Week High
- $0.817
- 52-Week Low
- $0.0351
- Analyst Target Price
- $
Heart Test Laboratories Inc. Warrant stock is currently trading at $0.1 per share. It touched a 52-week high of $0.817 and a 52-week low of $0.817. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.13 and 200-day moving average was $0.23 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Heart Test Laboratories Inc. Warrant
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor’s offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.